Abstract
Background
Anxiety, depression and pain catastrophizing are independently associated with risk of opioid misuse in patients with persistent pain but their relationship to current opioid misuse, when considered together, is poorly understood. This study will assess the relative contribution of these modifiable, and distinct psychological constructs to current opioid misuse in patients with persistent pain.
Methods
One hundred and twenty-seven patients referred to a specialized opioid management clinic for prescription opioid misuse within a tertiary pain service were recruited for this study. The Pain Catastrophizing Scale, Depression, Anxiety and Stress Scales and the Current Opioid Misuse Measure were administered pre-treatment. Pain severity and morphine equivalent dose based on independent registry data were also recorded.
Results
Higher levels of pain catastrophizing, depression, and anxiety were significantly associated with higher current opioid misuse (r = .475, 0.599, and 0.516 respectively, p < .01). Pain severity was significantly associated with pain catastrophizing (r = .301, p < .01). Catastrophizing, depression, and anxiety explained an additional 11.56% of the variance (R2 change = 0.34, p < .01) over and above age, gender, pain severity and morphine equivalent dose. Depression was the only significant variable at Step 2 (β = 0.62, p < .01).
Conclusion
Findings show that in a sample of people with persistent pain referred for treatment for opioid misuse, depression contributes over and above that of anxiety and pain catastrophizing. Theoretical and clinical practice implications are presented.
This is a preview of subscription content, log in via an institution to check access.
References
Aaron, R. V., Finan, P. H., Wegener, S. T., Keefe, F. J., & Lumley, M. A. (2020). Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use. American Psychologist, 75(6), 796. https://doi.org/10.1037/amp0000678.
Adewumi, A. D., Staatz, C. E., Hollingworth, S. A., Connor, J. P., & Alati, R. (2018). Prescription opioid fatalities: Examining why the healer could be the culprit. Drug Safety, 41(11), 1023–1033. https://doi.org/10.1007/s40264-018-0687-6.
Arteta, J., Cobos, B., Hu, Y., Jordan, K., & Howard, K. (2016). Evaluation of how depression and anxiety mediate the relationship between pain catastrophizing and prescription opioid misuse in a chronic pain population. Pain Medicine, 17(2), 295–303. https://doi.org/10.1111/pme.12886.
Asmundson, G. J., & Katz, J. (2009). Understanding the co-occurrence of anxiety disorders and chronic pain: State of the art. Depression and Anxiety, 26(10), 888–901. https://doi.org/10.1002/da.20600.
Barlow, D. H., Harris, B. A., Eustis, E. H., & Farchione, T. J. (2020). The unified protocol for transdiagnostic treatment of emotional disorders. World Psychiatry, 19(2), 245–246.
Beck, A. T., Steer, R. A., & Brown, O. K. (1996). Beck Depression Inventory manual (2nd ed.). Psychological Corporation.
Butler, S. F., Budman, S. H., Fernandez, K. C., Houle, B., Benoit, C., Katz, N., & Jamison, R. N. (2007). Development and validation of the current opioid misuse measure. Pain, 130(1–2), 144–156. https://doi.org/10.1016/j.pain.2007.01.014.
Carpenter, J. K., Andrews, L. A., Witcraft, S. M., Powers, M. B., Smits, J. A., & Hofmann, S. G. (2018). Cognitive behavioral therapy for anxiety and related disorders: A meta-analysis of randomized placebo‐controlled trials. Depression and Anxiety, 35(6), 502–514. https://doi.org/10.1002/da.22728.
Dunn, L. K., Durieux, M. E., Fernández, L. G., Tsang, S., Smith-Straesser, E. E., Jhaveri, H. F., & Naik, B. I. (2017). Influence of catastrophizing, anxiety, and depression on in-hospital opioid consumption, pain, and quality of recovery after adult spine surgery. Journal of Neurosurgery: Spine, 28(1), 119–126. https://doi.org/10.3171/2017.5.SPINE1734.
Garnet, B., Beitel, M., Cutter, C. J., Savant, J., Peters, S., Schottenfeld, R. S., & Barry, D. T. (2011). Pain catastrophizing and pain coping among methadone-maintained patients. Pain Medicine, 12(1), 79–86. https://doi.org/10.1111/j.1526-4637.2010.01002.x.
Goodyear, K., Haass-Koffler, C. L., & Chavanne, D. (2018). Opioid use and stigma: The role of gender, language and precipitating events. Drug and Alcohol Dependence, 185, 339–346. https://doi.org/10.1016/j.drugalcdep.2017.12.037.
Graham, J. W. (2009). Missing data analysis: Making it work in the real world. Annual Review of Psychology, 60, 549–576. https://doi.org/10.1146/annurev.psych.58.110405.085530.
Grattan, A., Sullivan, M. D., Saunders, K. W., Campbell, C. I., & Von Korff, M. R. (2012). Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. The Annals of Family Medicine, 10(4), 304–311. https://doi.org/10.1370/afm.1371.
Hoots, B. E., Xu, L., Kariisa, M., Wilson, N. O., Rudd, R. A., Scholl, L., & Seth, P. (2018). 2018 Annual surveillance report of drug-related risks and outcomes–United States.
Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2019). Systematic review and meta‐analysis: Dose–response curve of SSRIs and SNRIs in anxiety disorders. Depression and Anxiety, 36(3), 198–212. https://doi.org/10.1002/da.22854.
Kerns, R. D., Turk, D. C., & Rudy, T. E. (1985). The west haven-yale multidimensional pain inventory (WHYMPI). Pain, 23(4), 345–356. https://doi.org/10.1016/0304-3959(85)90004-1.
Kovitwanichkanont, T., & Day, C. A. (2018). Prescription opioid misuse and Public Health Approach in Australia. Substance Use & Misuse, 53(2), 200–205. https://doi.org/10.1080/10826084.2017.1305415.
Larance, B., Campbell, G., Moore, T., Nielsen, S., Bruno, R., Lintzeris, N., & Degenhardt, L. (2019). Concerns and help-seeking among patients using opioids for management of chronic noncancer pain. Pain Medicine, 20(4), 758–769. https://doi.org/10.1093/pm/pny078.
Lovibond, S. H., & Lovibond, P. F. (1995). Manual for the Depression anxiety stress scales (DASS). Psychology Foundation Monograph.
Martel, M. O., Wasan, A. D., Jamison, R. N., & Edwards, R. R. (2013). Catastrophic thinking and increased risk for prescription opioid misuse in patients with chronic pain. Drug and Alcohol Dependence, 132(1), 335–341. https://doi.org/10.1016/j.drugalcdep.2013.02.034.
Martinez-Calderon, J., Flores-Cortes, M., Morales-Asencio, J. M., & Luque-Suarez, A. (2021). Pain Catastrophizing, Opioid Misuse, Opioid Use, and Opioid Dose in People with Chronic Musculoskeletal Pain: A systematic review. The Journal of Pain, 22(8), 879–891. https://doi.org/10.1016/j.jpain.2021.02.002.
Mazereeuw, G., Sullivan, M. D., & Juurlink, D. N. (2018). Depression in chronic pain: Might opioids be responsible? Pain, 159(11), 2142–2145. https://doi.org/10.1097/j.pain.0000000000001305.
Meltzer, E. C., Rybin, D., Saitz, R., Samet, J. H., Schwartz, S. L., Butler, S. F., & Liebschutz, J. M. (2011). Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the current opioid misuse measure (COMM). Pain, 152(2), 397–402. https://doi.org/10.1016/j.pain.2010.11.006.
Rogers, A. H., Garey, L., Allan, N. P., & Zvolensky, M. J. (2021). Exploring transdiagnostic processes for chronic pain and opioid misuse among two studies of adults with chronic pain. Behaviour Research and Therapy, 136, 103786.
Schütze, R., Rees, C., Smith, A., Slater, H., Campbell, J. M., & O’Sullivan, P. (2018). How can we best reduce pain catastrophizing in adults with chronic noncancer pain? A systematic review and meta-analysis. The Journal of Pain, 19(3), 233–256. https://doi.org/10.1016/j.jpain.2017.09.010.
Smithson, M. (2001). Correct confidence intervals for various regression effect sizes and parameters: The importance of noncentral distributions in computing intervals. Educational and Psychological Measurement, 61(4), 605–632.
Sullivan, M. D. (2018). Depression effects on long-term prescription opioid use, abuse, and addiction. The Clinical Journal of Pain, 34(9), 878–884. https://doi.org/10.1097/AJP.0000000000000603.
Sullivan, M. J., Bishop, S. R., & Pivik, J. (1995). The pain catastrophizing scale: Development and validation. Psychological Assessment, 7(4), 524.
Tardif, H., Hayes, C., & Allingham, S. F. (2021). Opioid cessation is associated with reduced pain and improved function in people attending specialist chronic pain services. The Medical Journal of Australia, 214(9), 430–432.
Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., & Van Der Goes, D. N. (2015). Rates of opioid misuse, abuse, and addiction in chronic pain: A systematic review and data synthesis. Pain, 156(4), 569–576. https://doi.org/10.1097/01.j.pain.0000460357.01998.f1.
Acknowledgements
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Baranoff, J.A., Clubb, B., Coates, J.M. et al. The contribution of pain catastrophizing, depression and anxiety symptoms among patients with persistent pain and opioid misuse behaviours. J Behav Med 47, 342–347 (2024). https://doi.org/10.1007/s10865-023-00452-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10865-023-00452-4